Abstract:Novel extended thiazolotriazoles (8a–8j) and triazolothiadiazines (11a–11j), including aminotriazole intermediate 10, were synthesized. The compounds showed effective as well as selective inhibition toward tumor‐associated isoforms of human carbonic anhydrase (hCA IX and/or XII), over the off‐target hCAs I/II. Additionally, all compounds inhibited cathepsin B at a low concentration of 10–7 M. The present research focused on the tail‐approach synthesis of novel extended thiazolotriazoles (8a–8j) and triazolothiadiazines (11a–11j) including aminotriazole intermediate 10. After successful synthesis, all the compounds were evaluated for their inhibition potential against cytosolic isoforms of human carbonic anhydrase (hCA I, II), tumor‐linked transmembrane isoforms (hCA IX, XII), and cathepsin B. As per the inhibition data, the newly synthesized compounds showed poor inhibition against hCA I. Many of the compounds showed effective inhibition toward hCA IX and/or XII in low nanomolar concentration. Despite the strong to moderate inhibition of hCA II by these compounds, more than half of them demonstrated better inhibition against hCA IX and/or XII, comparatively. Further, insights of CA inhibition data of these extended analogs and their comparison with earlier reported thiazolotriazole and triazolothiadiazine derivatives might help in the rational design of novel potent and selective hCA IX and XII inhibitors. The novel compounds were also found to possess anti‐cathepsin B potential at a low concentration of 10−7 M. Broadly, compounds of series 11a–11j presented more effective inhibition against cathepsin B than their counterparts in series 8a–8j. Moreover, these in vitro results with respect to cathepsin B inhibition were also supported by the in silico insights obtained via molecular modeling studies.

Novel Thiol-Based Tace Inhibitors: Rational Design, Synthesis, and Sar of Thiol-Containing Aryl Sulfonamides

Novel Thiol‐Based TACE Inhibitors: Rational Design, Synthesis, and SAR of Thiol‐Containing Aryl Sulfonamides.

Design, Synthesis and Evaluation of 3-(2-aminoheterocycle)-4-benzyloxyphenylbenzamide Derivatives As BACE-1 Inhibitors

Greener liquid-phase synthesis and the ACE inhibitory structure-activity relationship of an anti-SARS octapeptide.

TDPBP Derivative Aiding Liquid-Phase Synthesis Strategy and ACE Inhibitory Structure-activity Relationship of Anti-SARS Octapeptide

Molecular Modeling and Biological Effects of Peptidomimetic Inhibitors of TACE Activity.

Design and Synthesis of 1,3,4-Thiadiazole Derivatives as Type IV Collagenase Inhibitors

Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitors.

Design, synthesis, and bioactivities of tasiamide B derivatives as cathepsin D inhibitors.

Sulfonamide Derivatives Containing Dihydropyrazole Moieties Selectively and Potently Inhibit Mmp-2/Mmp-9: Design, Synthesis, Inhibitory Activity and 3D-Qsar Analysis

1,2,3-thiadiazole thioacetanilides. Part 2: Synthesis and biological evaluation of a new series of 2-{[4-(3,4-dichlorophenyl)-1,2,3-thiadiazol-5-yl]sulfanyl}acetanilides as HIV-1 inhibitors.

Design and synthesis of potent and selective macrocyclic thrombin inhibitors

1,2,3-Thiadiazole Thioacetanilides As a Novel Class of Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.

Synthesis, Molecular Modeling and Biological Assessment of Aryloxymethyl 1,3,4-Thiadiazole and 1,2,4-Triazole-5-Thione Derivatives as Potential Cox Inhibitors

Design, Synthesis and Antitumor Evaluation of a New Series of N-substituted-thiourea Derivatives

Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors.

Novel thiazolotriazole and triazolothiadiazine scaffolds as selective tumor associated carbonic anhydrase inhibitors endowed with cathepsin B inhibition

Novel Benzoyl Thioureido Benzene Sulfonamides As Highly Potent and Selective Inhibitors of Carbonic Anhydrase IX: Optimization and Bioactive Studies.

Structure-based design and synthesis of novel P2/P3 modified, non-peptidic β-secretase (BACE-1) inhibitors

Design, Synthesis, and Biological Evaluation of 2-Substituted Ethenesulfonic Acid Ester Derivatives As Selective PTP1B Inhibitors.

Synthesis, Biological Evaluation, and Computational Studies of Schiff's Base Derivatives of 4‐(4‐Amino‐5‐mercapto‐4H‐1,2,4‐triazol‐3‐yl)benzenesulfonamide as Cathepsin B Inhibitors